Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Celluminova has raised $2.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Celluminova's investors include East Sweden Capital, Almi Invest.
Celluminova is headquartered in Norrköping, Sweden.
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Celluminova is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Celluminova — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/celluminova. Accessed August 13, 2026.
VCBacked. (2026). Celluminova — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/celluminova
{{cite web |title=Celluminova — Funding & Investors |url=https://www.vcbacked.co/company/celluminova |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated